---
title: "Mangalam Drugs and Organics Ltd (MANGALAM) — Share Price, Financials & Analysis"
symbol: "MANGALAM"
company: "Mangalam Drugs and Organics Ltd"
canonical: "https://tapetide.com/stocks/MANGALAM"
isin: "INE584F01014"
nse_symbol: "MANGALAM"
bse_code: "532637"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 55.08
generated_at: "2026-09-13T18:56:25.197Z"
---

# Mangalam Drugs and Organics Ltd (MANGALAM)

Canonical page: https://tapetide.com/stocks/MANGALAM

## Company

- **NSE Symbol:** MANGALAM
- **BSE Code:** 532637
- **ISIN:** INE584F01014
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2005-05-23
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** mangalamdrugs.com

## About

Incorporated in 1977, Mangalam Drugs & Organics Ltd manufactures Active Pharmaceutical Ingredients and Intermediates.[1]

## Latest Price

- **Price:** ₹36.46
- **Change:** +1.58 (+4.53%)
- **Open:** ₹35
- **Day High:** ₹38.25
- **Day Low:** ₹33.11
- **Previous Close:** ₹34.88
- **Volume:** 385169
- **As Of:** 2026-09-11T10:24:33+00:00

## Key Fundamentals

Observed at 2026-09-11T04:45:00.338413Z.

- **Market Cap:** ₹55.08 Cr
- **Classification:** Microcap
- **P/E (reported):** -1.4
- **EPS (TTM):** ₹-23.78
- **Book Value:** ₹60.64
- **Price to Book:** 0.57
- **Dividend Yield:** 0%
- **ROE:** 4.51%
- **ROCE:** 11.28%
- **Debt to Equity:** 1.02
- **Revenue (yearly):** ₹232.13 Cr
- **Net Income:** ₹-48.86 Cr
- **EBITDA:** ₹-14.91 Cr
- **52-Week High:** ₹79.49
- **52-Week Low:** ₹22.8
- **RSI (14):** 71.84

## Tapetide Score

- **Score:** 40 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 14.5 (of 4473 scored stocks)
- **Confidence:** 91%
- **Data coverage:** 81%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 11.84 | 9% |
| growth | 13.65 | 9% |
| momentum | 47.3 | 12% |
| ownership | 45.61 | 24% |
| quality | 42.89 | 22% |
| valuation | 45.59 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.56 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -9.39% over past five years.
- Promoter holding is low: 35.6%
- Company has a low return on equity of -11.0% over last 3 years.
- Contingent liabilities of Rs.34.6 Cr.
- Debtor days have increased from 45.3 to 63.4 days.
- Promoter holding has decreased over last 3 years: -14.7%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 989.26% | — | — |
| ebitda margin growth | 118.18% | -156.14% | -234.74% | — |
| net income growth | 43.28% | -829.25% | 436.92% | — |
| revenue growth | -15.13% | -27.16% | -15% | -9% |
| roce | -69.87% | 571.43% | 571.43% | — |
| roe | -43.07% | -167.51% | -1.09% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 81.56 | 97.34 | 102.24 | 76.53 | 79.94 | 88.71 | 72.78 | 57.21 | 49.54 | 58.38 | 67.29 | 57.12 |
| Expenses | 79.37 | 90.36 | 90.54 | 68.34 | 71.25 | 79.94 | 62.88 | 61.86 | 52.37 | 59.96 | 72.65 | 56.22 |
| Operating Profit | 2.19 | 6.98 | 11.7 | 8.19 | 8.69 | 8.77 | 9.9 | -4.65 | -2.83 | -1.58 | -5.36 | 0.9 |
| OPM % | 2.69 | 7.17 | 11.44 | 10.7 | 10.87 | 9.89 | 13.6 | -8.13 | -5.71 | -2.71 | -7.97 | 1.58 |
| Other Income | 0.03 | 0 | 0.05 | 0.02 | 0.14 | 0.13 | 0.47 | 0.14 | 0.03 | 0.22 | 0.09 | 0.11 |
| Interest | 3.24 | 3.31 | 3.95 | 3.75 | 3.67 | 3.49 | 4.03 | 4.04 | 5.03 | 4.05 | 3.08 | 3.68 |
| Depreciation | 3.73 | 3.62 | 3.86 | 3.87 | 3.97 | 3.93 | 4.61 | 4.38 | 4.53 | 4.37 | 4.56 | 3.99 |
| Profit before tax | -4.75 | 0.05 | 3.94 | 0.59 | 1.19 | 1.48 | 1.73 | -12.93 | -12.36 | -9.78 | -12.91 | -6.66 |
| Tax % | -25.05 | -920 | 9.9 | -355.93 | -125.21 | 5.41 | 90.75 | 6.19 | -41.42 | 0 | 1.16 | 13.36 |
| Net Profit | -3.56 | 0.5 | 3.55 | 2.68 | 2.69 | 1.4 | 0.15 | -13.73 | -7.25 | -9.78 | -13.06 | -7.55 |
| EPS in Rs | -2.25 | 0.32 | 2.24 | 1.69 | 1.7 | 0.88 | 0.09 | -8.67 | -4.58 | -6.18 | -8.25 | -4.77 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 269 | 228 | 282 | 380 | 451 | 372 | 369 | 318 | 232 | 232 |
| Expenses | 222 | 218 | 259 | 327 | 402 | 347 | 351 | 282 | 247 | 241 |
| Operating Profit | 47 | 10 | 24 | 53 | 49 | 26 | 17 | 36 | -15 | -9 |
| OPM % | 17 | 4.3 | 8 | 14 | 11 | 7 | 4.7 | 11 | -6 | -3.8 |
| Other Income | 1 | 0 | 1 | 5 | 0 | 0 | 0 | 0 | 1 | 0 |
| Interest | 12 | 9 | 10 | 9 | 11 | 13 | 14 | 15 | 16 | 16 |
| Depreciation | 7 | 7 | 8 | 9 | 10 | 11 | 15 | 16 | 18 | 17 |
| Profit before tax | 29 | -6 | 6 | 40 | 28 | 2 | -11 | 5 | -48 | -42 |
| Tax % | 32 | 40 | -32 | 29 | 29 | 43 | -18 | -39 | -9 | — |
| Net Profit | 20 | -8 | 8 | 28 | 20 | 1 | -9 | 7 | -44 | -38 |
| EPS in Rs | 12.57 | -5.07 | 5.21 | 17.67 | 12.42 | 0.8 | -5.72 | 4.37 | -27.68 | -23.78 |
| Dividend Payout % | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 70 | 88 | 80 | 88 | 115 | 135 | 136 | 127 | 133 | 87 |
| Borrowings | 66 | 69 | 65 | 52 | 70 | 88 | 89 | 107 | 96 | 105 |
| Other Liabilities | 38 | 54 | 50 | 75 | 64 | 90 | 117 | 108 | 114 | 99 |
| Total Liabilities | 190 | 227 | 211 | 231 | 264 | 328 | 358 | 357 | 359 | 308 |
| Fixed Assets | 93 | 102 | 103 | 101 | 118 | 135 | 142 | 147 | 156 | 152 |
| CWIP | 0 | 0 | 0 | 1 | 6 | 6 | 9 | 8 | 3 | 0 |
| Investments | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 95 | 125 | 107 | 128 | 140 | 188 | 206 | 202 | 201 | 156 |
| Total Assets | 190 | 227 | 211 | 231 | 264 | 328 | 358 | 357 | 359 | 308 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 43 | 25 | 22 | 31 | 28 | 26 | 38 | 12 | 43 | 4 |
| Cash from Investing Activity | -39 | -16 | -9 | -7 | -31 | -27 | -22 | -18 | -19 | -12 |
| Cash from Financing Activity | -3 | -9 | -11 | -23 | 3 | 3 | -17 | 6 | -22 | 6 |
| Net Cash Flow | 0 | 0 | 1 | 0 | -1 | 1 | -1 | 0 | 2 | -2 |
| Free Cash Flow | 3 | 9 | 12 | 24 | -4 | -2 | 16 | -6 | 23 | -8 |
| CFO/OP | 107 | 66 | 223 | 129 | 69 | 70 | 148 | 71 | 119 | -30 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 45 | 61 | 28 | 52 | 52 | 38 | 46 | 28 | 45 | 63 |
| Inventory Days | 69 | 132 | 175 | 121 | 85 | 139 | 200 | 185 | 303 | 239 |
| Days Payable | 38 | 82 | 77 | 106 | 63 | 65 | 139 | 124 | 199 | 160 |
| Cash Conversion Cycle | 75 | 111 | 126 | 67 | 74 | 112 | 107 | 88 | 148 | 142 |
| Working Capital Days | 19 | 31 | 21 | 10 | 23 | 43 | 38 | 18 | 13 | -54 |
| ROCE % | 31 | 25 | 2 | 11 | 27 | 18 | 6 | 1 | 8 | -14 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 50.32% | 50.32% | 50.32% | 50.32% | 50.3% | 50.3% | 50.3% | 50.3% | 50.3% | 35.64% | 35.65% | 35.65% |
| FIIs | 0% | 0.1% | 0.26% | 0.21% | 0.11% | 0.11% | 0.47% | 0.53% | 0.11% | 0.13% | 0.32% | 0.11% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 44.54% | 44.43% | 44.22% | 44.7% | 44.91% | 44.78% | 44.55% | 44.53% | 45% | 57.52% | 60.14% | 60.51% |
| Others | 5.14% | 5.15% | 5.2% | 4.77% | 4.67% | 4.8% | 4.68% | 4.63% | 4.59% | 6.7% | 3.89% | 3.73% |
| No. of Shareholders | 17978 | 18610 | 19173 | 19312 | 19508 | 19679 | 19697 | 19728 | 19881 | 21227 | 25140 | 24465 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 3 / 5

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 31.42 | Buy |
| EMA (10) | 32.12 | Buy |
| SMA (20) | 30.52 | Buy |
| EMA (20) | 30.88 | Buy |
| SMA (50) | 28.63 | Buy |
| EMA (50) | 29.57 | Buy |
| SMA (100) | 28.9 | Buy |
| EMA (100) | 30.21 | Buy |
| SMA (200) | 30.39 | Buy |
| EMA (200) | 36.61 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 75.26 | Sell |
| MACD (12,26,9) | 1.37 | Buy |
| Stochastic (14,3,3) | 83.52 | Sell |
| ADX (14) | 22.72 | Neutral |
| Williams %R (14) | -18.38 | Sell |
| ATR (14) | 2.22 | High Volatility |
| ROC (12) | 16.08 | Buy |
| Stoch RSI (14) | 84.1 | Sell |
| UO (7,14,28) | 62.44 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81656cb1-ef9d-48be-8eb3-9ce4b7071b43.pdf) |
| 2026-08-31 | [Intimation Of 53Rd Annual General Meeting To Be Held On Wednesday September 23Rd 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=519baf7e-8d15-4015-b692-a376b79ba50f.pdf) |
| 2026-08-31 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa650032-08d4-4acc-ab36-b9afc73e6770.pdf) |
| 2026-08-17 | [Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=890b1afa-ac4c-47aa-bec5-6fbebe36d0b7.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88ba3397-99f7-4f0f-a257-fe3775f0d42b.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August 2026 Interalia For Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b19f33d8-7650-4db8-a573-230b06745c5b.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c5cd308-d18d-4734-a31e-b923baed4549.pdf) |
| 2026-08-12 | [Appointment Of Secretarial Auditor Of The Company For Term Of 5 Years Subject To Approval Of Shareholders In Ensuing 53Rd Annaul General Meeting Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a959cb2-b11b-4379-b104-7e0356ef6780.pdf) |
| 2026-08-06 | [Intimation Of Resignation Tendered By Ragini Chokshi & Co. Secretarial Auditor Of The Company W.E.F. 4Th August 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6386e7a-8aed-489a-84b9-1194d789a30c.pdf) |
| 2026-08-05 | [Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On August 12Th 2026 Inter Alia To Approve Un-Audited Financial Results(Standalone & Consolidated) Alongwith Limited Review Report For The Quarter Ended 30Th June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86ae9201-ce53-4089-a682-8ca6fb622145.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Declaration Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86c25d8b-fdf0-4356-b494-d459810db53f.pdf) |
| 2026-05-14 | [Approval Of Audited Financial Results For The Quarter Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4636372-47cb-4ffc-8af2-f1eba3bc91b2.pdf) |
| 2026-01-15 | [Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e761af5-adeb-4ec6-9b55-862f26c2d29f.pdf) |
| 2025-11-20 | [Declaration Of Un-Audited Financial Results For The Quarter Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79504818-5127-47b5-b291-137999507c8c.pdf) |
| 2025-11-13 | [Results-Delay in Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=191e47b8-834f-4583-ba6c-3d55c9144f7e.pdf) |
| 2025-08-07 | [Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c75f665e-125a-42a5-b368-94acc4d2071a.pdf) |
| 2025-08-07 | [Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18b7419f-f602-4a5d-9d1e-adaa40b02b91.pdf) |
| 2025-05-17 | [Approval Of Financial Results For The Quarter And Year Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1d65f51-a469-4a58-8983-704c6555b157.pdf) |
| 2025-02-13 | [Declaration Of Un-Audited Financial Results For The Quarter Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08bb68bb-d8dc-41c9-b0f0-e3396753266e.pdf) |
| 2024-11-14 | [Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6034a3e2-b62a-4432-8705-7e88ba896e1b.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Defaults: Bank of Maharashtra ₹707.05 lacs and Bank of Baroda ₹446.71 lacs as of 17/12/2025. | [Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure 9h - Defaults: Bank of Maharashtra ₹707.05 lacs and Bank of Baroda ₹446.71 lacs as of 17/12/2025.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/63a667e2-07b9-42b9-88ad-d96fc402fcfa.pdf) |
| 9h - Defaulted on Bank of Maharashtra Rs1,040.71L (from 17/10/2025) and Bank of Baroda Rs514.92L (from 20/10/2025). | [Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure 9h - Defaulted on Bank of Maharashtra Rs1,040.71L (from 17/10/2025) and Bank of Baroda Rs514.92L (from 20/10/2025).](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0cbb7993-e21a-41c1-ba12-b5597e0c8478.pdf) |
| 9h - Default: Rs 979.21L to Bank of Maharashtra and Rs 606.08L to Bank of Baroda; defaults from Oct 2025. | [Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure 9h - Default: Rs 979.21L to Bank of Maharashtra and Rs 606.08L to Bank of Baroda; defaults from Oct 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/bddc348c-726b-4a0d-8492-433d58f9676c.pdf) |
| 6 May - Board meeting on May 14, 2026 to approve audited Q4 and FY26 results; trading window closed from April 1. | [Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th May, 2026 Inter-Alia To Approve Audited Financial Results(Standalone & Consolidated) Of The Company For The Period Ended 31St March, 2026 6 May - Board meeting on May 14, 2026 to approve audited Q4 and FY26 results; trading window closed from April 1.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/50ed67e8-26f6-49ed-9d44-00f6156b3504.pdf) |
| 6 Feb - CFO Jeevan M. Dalvi appointed w.e.f. 06-Feb-2026; Independent Director R. Dhandhania resigned 16-Jan-2026; Praveen Saxena reappointed 21-Mar-2026–20-Mar-2031. | [Board Meeting Outcome for Outcome Of Board Meeting Dated 6Th February 2026 6 Feb - CFO Jeevan M. Dalvi appointed w.e.f. 06-Feb-2026; Independent Director R. Dhandhania resigned 16-Jan-2026; Praveen Saxena reappointed 21-Mar-2026–20-Mar-2031.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/975fbfd4-711f-48dd-b1dc-4cb4cb02d207.pdf) |
| 6 Feb - CFO Jeevan Dalvi appointed effective 6 Feb 2026; R.P. Dhandhania resigned effective 16 Jan 2026; Dr. Saxena reappointed 21 Mar 2026 (subject to shareholder approval). | [Announcement under Regulation 30 (LODR)-Change in Management 6 Feb - CFO Jeevan Dalvi appointed effective 6 Feb 2026; R.P. Dhandhania resigned effective 16 Jan 2026; Dr. Saxena reappointed 21 Mar 2026 (subject to shareholder approval).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5b44d5c6-3910-4cbc-8cfc-a9eb96e6a29b.pdf) |
| 6 Apr - Submission of Compliance Certificate received from RTA under Regulation 74(5) of SEBI(DP) Regulations, 2018 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Submission of Compliance Certificate received from RTA under Regulation 74(5) of SEBI(DP) Regulations, 2018](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1ec04461-0fa7-4075-b612-08549f87eec4.pdf) |
| 4 Feb - Board meeting Feb 6: appoint CFO Jeevan M. Dalvi; note Rukmesh Dhandhania resignation (w.e.f Jan 16); reappoint Dr. Praveen Saxena. | [Board Meeting Intimation for To Consider And Approve Appointment Of Chief Financial Officer Of The Company And Any Other Businesses. 4 Feb - Board meeting Feb 6: appoint CFO Jeevan M. Dalvi; note Rukmesh Dhandhania resignation (w.e.f Jan 16); reappoint Dr. Praveen Saxena.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/88452f5f-678b-4dc5-ab8a-69be6d66466e.pdf) |
| 3 Feb - Crisil downgraded to Crisil D on Nov 24, 2025; Rs115 crore facilities; defaults, overdrafts. | [Announcement under Regulation 30 (LODR)-Credit Rating 3 Feb - Crisil downgraded to Crisil D on Nov 24, 2025; Rs115 crore facilities; defaults, overdrafts.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/01996188-b0be-438a-81ad-ebda8498c809.pdf) |
| 26 Mar - Company Secretary Anuradha Pandey resigns effective 29 Mar 2026; Shweta Patel appointed effective 1 Apr 2026. | [Board Meeting Outcome for Outcome Of Board Meeting For Resignation Tendered By CS Anuradha Pandey Accepted By The Board, Approval For The Appointment Of New Company Secretary Nominated By NRC, Ms. Shweta Patel. 26 Mar - Company Secretary Anuradha Pandey resigns effective 29 Mar 2026; Shweta Patel appointed effective 1 Apr 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e9c81204-398d-4ccb-bfc6-3c7541cc00c1.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_1449_MANGALAM_2012_2013_05092013143322.zip) |
| from nse | [Annual Report 2012 from nse](https://archives.nseindia.com/annual_reports/AR_MANGALAM_2011_2012_12102012053636.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aac0943e-bf1d-456a-b8e9-d553da964c73.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c16ca491-8092-4f35-b664-811261ec2768.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c399dbed-1415-48d3-9779-d3e63e9c8a56.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532637/75364532637.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532637/70592532637.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532637/65569532637_23_12_20.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532637/5326370319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/532637/5326370318.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| May 2016 | [Concall - May 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=214ACAB6_B34A_49B9_B6B8_B0276951FD0B_152933.pdf) |
| Feb 2016 | [Concall - Feb 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=A181D847_2C62_472B_B2B5_D926306D0ABD_124459.pdf) |
| Aug 2016 | [Concall - Aug 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=DB345E2E_6684_4596_B388_2693480C4D6A_175102.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:56:25.197Z.